We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

34 hedge funds and large institutions have $36.2M invested in OncoSec Medical Incorporated in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 4

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

32% more capital invested

Capital invested by funds: $27.4M → $36.2M (+$8.76M)

10% more funds holding

Funds holding: 31 → 34 (+3)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
17
Reduced
4
Closed
6
Calls
$59K
Puts
–
Net Calls
+$59K
Net Calls Change
+$59K

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$9.44M
2
Holocene Advisors
Holocene Advisors
New York
+$4M
3
JGC
J. Goldman & Co
New York
+$2.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.48M
5
CC
Caxton Corporation
New Jersey
+$721K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$801K
2
SFP
Sandbox Financial Partners
Maryland
-$484K
3
SSA
Schonfeld Strategic Advisors
New York
-$401K
4
BFM
Boothbay Fund Management
New York
-$132K
5
Goldman Sachs
Goldman Sachs
New York
-$120K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$25K +$5.06K +37 +19%
SFS
27
Sowell Financial Services
Arkansas
$13K +$15.5K +113 +332%
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$8K +$9.99K +73 New
UBS Group
29
UBS Group
Switzerland
$5K -$11.5K -84 -64%
Barclays
30
Barclays
United Kingdom
$4K +$5.47K +40 New
Osaic Holdings
31
Osaic Holdings
Arizona
$3K +$1.23K +9 +47%
Bank of America
32
Bank of America
North Carolina
$1K – – –
Wells Fargo
33
Wells Fargo
California
$1K +$411 +3 +75%
WAP
34
Wealthcare Advisory Partners
Pennsylvania
$1K +$958 +7 New
6CM
35
683 Capital Management
New York
– -$801K -5,645 Closed
SFP
36
Sandbox Financial Partners
Maryland
– -$484K -3,409 Closed
BFM
37
Boothbay Fund Management
New York
– -$132K -928 Closed
Goldman Sachs
38
Goldman Sachs
New York
– -$120K -845 Closed
Marshall Wace
39
Marshall Wace
United Kingdom
– -$102K -718 Closed
DWA
40
Dorsey Wright & Associates
California
– -$14K -98 Closed
1
2

ONCS Hedge Fund Activity: Q1 2021 in Review

34 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2021, worth a combined $36.2M — up 32% from $27.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ONCS positions and 6 closed out — a net gain of 4 holders — while 17 added to existing stakes and 4 trimmed.

The largest buyer was Avidity Partners Management, adding an estimated $9.44M. The largest seller was 683 Capital Management, exiting entirely with an estimated $801K sold.

  • 34 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2021, up from 31 in Q4 2020.
  • Funds reported $36.2M of OncoSec Medical Incorporated stock for Q1 2021, up 32% quarter-over-quarter.
  • 10 funds opened new OncoSec Medical Incorporated positions in Q1 2021 and 6 closed out, a net change of +4 holders.
  • The largest OncoSec Medical Incorporated buyer in Q1 2021 was Avidity Partners Management, an estimated $9.44M added.
  • The largest OncoSec Medical Incorporated seller in Q1 2021 was 683 Capital Management, an estimated $801K sold.

Based on aggregated 13F filings for Q1 2021.